A Case of Systemic Mastocytosis Associated with Acute Myeloid Leukemia Terminating as Aleukemic Mast Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
In up to 40% of systemic mastocytosis (SM) cases, an associated clonal hematological non-mast cell lineage disease such as AML is diagnosed before, simultaneously with, or after the diagnosis of SM. A 40-yr-old man was diagnosed with AML with t(8;21)(q22;q22). Mast cells were not noted at diagnosis, but appeared as immature forms at relapse. After allogeneic hematopoietic stem cell transplantation (HSCT), leukemic myeloblasts were not observed; however, neoplastic metachromatic blasts strikingly proliferated during the state of bone marrow aplasia, and finally, aleukemic mast cell leukemia developed. As the disease progressed, we observed serial morphologic changes from immature mast cells with myeloblasts to only metachromatic blasts and atypical mast cells as mast cell leukemia;FISH analysis showed that the neoplastic mast cells originated from the same clone as the leukemic myeloblasts of AML.
Abstract
In up to 40% of systemic mastocytosis (SM) cases, an associated clonal hematological non-mast cell lineage disease such as AML is diagnosed before, simultaneously with, or after the diagnosis of SM. A 40-yr-old man was diagnosed with AML with t(8;21)(q22;q22). Mast cells were not noted at diagnosis, but appeared as immature forms at relapse. After allogeneic hematopoietic stem cell transplantation (HSCT), leukemic myeloblasts were not observed; however, neoplastic metachromatic blasts strikingly proliferated during the state of bone marrow aplasia, and finally, aleukemic mast cell leukemia developed. As the disease progressed, we observed serial morphologic changes from immature mast cells with myeloblasts to only metachromatic blasts and atypical mast cells as mast cell leukemia;FISH analysis showed that the neoplastic mast cells originated from the same clone as the leukemic myeloblasts of AML.
참고문헌 (15)
- Horny HP, "Mastocytosis, In WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed", pp.54~63 (2008), IARC Press
- Lim KH, "Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors", Blood, 113, pp.5727~5736 (2009)
- Valent P, "Mastocytosis: pathology, genetics, and current options for therapy", Leuk Lymphoma, 46, pp.35~48 (2005)
- Schnittger S, "KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival", Blood, 107, pp.1791~1799 (2006)
- Valent P, "Diagnostic criteria and classification of mastocytosis: a consensus proposal", Leuk Res, 25, pp.603~625 (2001)
- Sperr WR, "Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val", Br J Haematol, 103, pp.740~749 (1998)
- Escribano L, "Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis", J Allergy Clin Immunol, 114, pp.28~33 (2004)
- Bernd HW, "Acute myeloid leukaemia with t(8;21) associated with “occult” mastocytosis. Report of an unusual case and review of the literature", J Clin Pathol, 57, pp.324~328 (2004)
- Pullarkat V, "Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone", Leuk Res, 31, pp.261~265 (2007)
- Nagai S, "The origin of neoplastic mast cells in systemic mastocytosis with AML1", ETO-positive acute myeloid leukemia, 2007, pp.35, 1747~1752
- Paschka P, "Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study", J Clin Oncol, 24, pp.3904~3911 (2006)
- Sperr WR, "Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation", Clin Cancer Res, 11, pp.6787~6792 (2005)
- Chen TY, "Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation", Bone Marrow Transplant, 32, pp.111~114 (2003)
- Parker RI, "Hematologic aspects of systemic mastocytosis", Hematol Oncol Clin North Am, 14, pp.557~568 (2000)
- Spyridonidis A, "Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation", Bone Marrow Transplant, 34, pp.515~519 (2004)